Inventor profile of:

Eike Staub

City:

Darmstadt

Country:

Germany

Published Applications:

10

Last publication date:

2023-10-12

Top Assignees for applications by Eike Staub

The entities that hold a legal rights for patent applications filed by inventor Staub Eike:

Recent patent applications by Staub Eike

Eike Staub from Darmstadt, DE has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2023-10-12
US20230322934A1
Chemistry; metallurgy

Anti-alpha-v integrin antibody for the treatment of fibrosis and/or fibrotic disorders

#2 | 2022-10-20
US20220334117A1
Physics

Method of treating solid cancers and/or metastases thereof, medicaments therefore, and a method of predicting the clinical outcome of treating solid cancers and/or metastases thereof

#3 | 2022-09-01
US20220275094A1
Chemistry; metallurgy

Method of treating bone metastasis diseases, medicaments therefore, and a method of predicting the clinical outcome of treating bone metastasis diseases

#4 | 2020-01-02
US20200002424A1
Chemistry; metallurgy

Anti-alpha-v integrin antibody for the treatment of fibrosis and/or fibrotic disorders

#5 | 2019-11-07
US20190338037A1
Chemistry; metallurgy

Method of treating bone metastasis diseases, medicaments therefore, and a method of predicting the clinical outcome of treating bone metastasis diseases

#6 | 2019-05-16
US20190144547A1
Chemistry; metallurgy

ANTI-ALPHA-V INTEGRIN ANTIBODY FOR THE TREATMENT OF FIBROSIS AND/OR FIBROTIC DISORDERS

#7 | 2017-10-19
US20170298134A1
Chemistry; metallurgy

Method of treating solid cancers and/or metastases thereof with pan AV integrin inhibitor, medicaments therefore, and a method of predicting the clinical outcome of treating solid cancers and/or metastases thereof

#8 | 2017-10-19
US20170298133A1
Chemistry; metallurgy

Method of treating bone metastasis diseases, medicaments therefore, and a method of predicting the clinical outcome of treating bone metastasis diseases

#9 | 2016-07-28
US20160215348A1
Chemistry; metallurgy

GENE EXPRESSION BIOMARKERS AND THEIR USE FOR DIAGNOSTIC AND PROGNOSTIC APPLICATION IN PATIENTS POTENTIALLY IN NEED OF HDAC INHIBITOR TREATMENT

#10 | 2014-05-29
US20140148457A1
Chemistry; metallurgy

Thiazole derivatives

InventorID:

779537 ⎘